MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-19-0016998
Unipact Pharmaceuticals Private Limited
Unipact Pharmaceuticals Private Limited - chemicals in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.21 Cr
▼ 4% YoY
Net profit · FY 2025
₹3.13 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹4.41 Lakh
EBITDA margin 3.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Unipact Pharmaceuticals Private Limited
Data last updated:
Unipact Pharmaceuticals Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 07 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2020PTC068432. Its GSTIN is 23AACCU6418R1ZV (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Umesh Kumar Saxena and Aman Bhalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jabalpur, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.13 Lakh (net margin 2.6%) and EBITDA of ₹4.41 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
Unipact Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0016998).
Company details
CIN U24230MP2020PTC068432
Registration Number 068432
Incorporation Date 07 August 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0016998
CIN history
Unipact Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH2020PTC343478. The current CIN is U24230MP2020PTC068432, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MP2020PTC068432 | Current |
| U24230MH2020PTC343478 | Previous |
Key People
Umesh Kumar Saxena Director Aman Bhalla Director Recognitions & Rankings of Unipact Pharmaceuticals
Contact details
Unipact Pharmaceuticals Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH No – 403 Kripal Chouck, Chandrikachal Appartment, Jabalpur, Madhya Pradesh, India – 482001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Unipact Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Unipact Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unipact Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unipact Pharmaceuticals Private Limited, buy the company report.
Financials of Unipact Pharmaceuticals Private Limited
FY 2025 filings availableUnipact Pharmaceuticals Private Limited reported revenue of ₹1.21 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹1.21 Cr ▼ 4%
Net profit · FY 2025
₹3.13 Lakh margin 2.6%
EBITDA · FY 2025
₹4.41 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 41%
Revenue fell 4% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 41%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unipact Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unipact Pharmaceuticals Private Limited
Unipact Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Kumar Saxena | Director | 07 Aug 2020 | 6 Years 2 Months | Current |
| Aman Bhalla Also directs: Maa Pitambara Outsourcing Private Limited | Director | 07 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Unipact Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unipact Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unipact Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Unipact Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCU6418R1ZV | Madhya Pradesh | Active | 30 Sep 2020 |
To see the full GST registrations and return filing status of Unipact Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unipact Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Aman Bhalla was appointed as Director on 07 Aug 2020.
AGM
Unipact Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unipact Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Aman Bhalla was appointed as Director.
Appointed
Umesh Kumar Saxena was appointed as Director.
Incorporation
07 Aug 2020
Unipact Pharmaceuticals Private Limited was registered on 07 Aug 2020 with Roc Gwalior & aged 6 years 2 months as per MCA records.
Frequently asked questions
Unipact Pharmaceuticals is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 07 August 2020 (6+ years old) and is registered under CIN U24230MP2020PTC068432.
Unipact Pharmaceuticals has 2 current directors:
- Umesh Kumar Saxena - Director
- Aman Bhalla - Director
The latest financial statements of Unipact Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Unipact Pharmaceuticals is 23AACCU6418R1ZV, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Unipact Pharmaceuticals is U24230MP2020PTC068432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unipact Pharmaceuticals was incorporated on 07 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
Aman Bhalla was appointed as Director on 07 Aug 2020. Umesh Kumar Saxena was appointed as Director on 07 Aug 2020.
Yes, Unipact Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0016998).
The registered office of Unipact Pharmaceuticals is at H No – 403 Kripal Chouck, Chandrikachal Appartment, Jabalpur, Madhya Pradesh, India – 482001.
Unipact Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages